Stephen K Doberstein

CIK 1480111 · SVP & Chief Scientific Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.39M

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$30.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FBRX Director $17.56 $0 6 2026-06-02
Dicerna Pharmaceuticals Inc (DRNA) Delisted Director 0 $38.22 $0 $0 4 2021-12-29
NKTR SVP & Chief Scientific Officer 107,668 $59.38 $6.39M -$30.48M 32 2019-09-09

Recent Filings · Page 2 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-09-09 NKTR Buy (P) +15,000 $259.2K EDGAR
2019-08-19 NKTR Sell (S) −3,245 -$58.9K EDGAR
2019-05-17 NKTR Sell (S) −3,461 -$108.6K EDGAR
2019-02-21 NKTR Sell (S) −3,310 -$140.3K EDGAR
2018-12-18 NKTR Grant (A) +23,950 $0 EDGAR
2018-11-19 NKTR Sell (S) −4,524 -$173.0K EDGAR
2018-08-16 NKTR Mixed +19,299 -$391.3K EDGAR
2018-05-18 NKTR Sell (S) −3,435 -$286.4K EDGAR
2018-04-09 NKTR Mixed -$13.53M EDGAR
2018-02-20 NKTR Sell (S) −2,426 -$201.2K EDGAR
Showing 1120 of 42
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.